Search

everythinglearnresearchcommunity

for

Search:↓

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Triamcinolone is more effective and safer for treating feline pemphigus foliaceus than prednisone.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Ultraviolet light helped hair growth more effectively than triamcinolone acetonide.

Use lower concentrations of triamcinolone acetonide to reduce steroid-induced scalp atrophy.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.

Adding Triamcinolone to the anesthetic can reduce swelling after hair transplants, and using Platelet-Rich Plasma can improve hair thickness and patient satisfaction. The SRD5A2 gene also plays a key role in the success of hair transplants.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Triamcinolone acetonide injections help regrow hair in alopecia areata patients.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Higher doses of prednisone and triamcinolone acetonide successfully treated 8 out of 10 alopecia totalis patients.

Use corticosteroid cream and triamcinolone injections for treating alopecia areata, and consider wigs and tranquilizers for support.

Alopecia areata mainly affects young people and has significant psychological impacts, especially in males.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

Intralesional steroid injections are safe and effective for treating severe alopecia areata.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.